13 July 2020 SYNLAB UK & Ireland and Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring…
7th April 2020 – SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully…
21 January 2020 SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB…
16 December 2019 SYNLAB UK & Ireland is delighted to announce Pathology First has been shortlisted as a finalist in the category of Best Healthcare…
Jul 2019 – SYNLAB have announced the launch of Faecal Immunochemical Testing (FIT), a bowel / colorectal cancer screening test. FIT is a more sensitive…
Jul 2019 – As part of National Biomedical Science Day, the Christie Pathology Partnership (CPP), based at The Christie in Manchester, opened its doors and…
Matt Jeffery, Operations Manager at Pathology First explains how he achieved his role, how the profession is evolving and what it’s like to lead the…
Following NICE approval in December 2018 a companion diagnostic test is required to determine PD-L1 levels in the tumour tissue of cisplatin-ineligible patients with locally…
Jamie Wild is a Biomedical Scientist (BMS) at the Christie Pathology Partnership (CPP), one of the UK’s leading reference centres specialising in cancer detection and…
Blood, Sweat and Samples – Pathology explained during National Pathology Week Staff at The Christie Pathology Partnership (CPP) celebrated National Pathology Week with a programme…
(CE_6) 2014_Adler_BMC-Gastroenterology (2)
Performance of the neoBona test: a new paired-end massively parallel shotgun sequencing approach for cell-free DNA-based aneuploidy screening Published online 28 February 2017 in Wiley…